Zobrazeno 1 - 10
of 680
pro vyhledávání: '"Jens F, Rehfeld"'
Autor:
Birgitte S. Wulff, Rune Ehrenreich Kuhre, Madhan Selvaraj, Jens F. Rehfeld, Kristoffer Niss, Johannes J. Fels, Secher Anna, Kirsten Raun, Marina Kjaergaard Gerstenberg
Publikováno v:
Heliyon, Vol 10, Iss 12, Pp e32009- (2024)
Objective: Co-treatment with long acting PYY and the GLP-1 receptor agonists has potential as an efficient obesity treatment. This study investigates whether the mechanisms behind additive reduction of food intake and weight loss depends on complemen
Externí odkaz:
https://doaj.org/article/4c1a17d3a0794a50bafbe1ca28b42027
Autor:
Bjarke R Medici, Birte Nygaard, Jeppe L la Cour, Martin Krakauer, Andreas Brønden, Mette P Sonne, Jens J Holst, Jens F Rehfeld, Tina Vilsbøll, Jens Faber, Filip K Knop
Publikováno v:
Endocrine Connections, Vol 12, Iss 10, Pp 1-14 (2023)
Context: In individuals with hypothyroidism and overweight, levothyroxine substitution therapy is often expected to cause weight loss due to its effect on resting energy expenditure. However, despite levothyroxine-induced enhancement of resting energ
Externí odkaz:
https://doaj.org/article/53d4a5a4ee254705a40789686a1d3ba7
Autor:
Martin L. Kårhus, David P. Sonne, Martin Thomasen, Anne-Marie Ellegaard, Jens J. Holst, Jens F. Rehfeld, Oscar Chávez-Talavera, Anne Tailleux, Bart Staels, Dennis S. Nielsen, Lukasz Krych, Lars O. Dragsted, Tina Vilsbøll, Andreas Brønden, Filip K. Knop
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 3, Pp 299-312 (2022)
Background and Aims: Bile acid malabsorption (BAM) is a debilitating disease characterized by loose stools and high stool frequency. The pathophysiology of BAM is not well-understood. We investigated postprandial enterohepatic and gluco-metabolic phy
Externí odkaz:
https://doaj.org/article/f76919d4a1ab4a769b0d39a75d0aa3b1
Autor:
Mads N. Thomsen, Mads J. Skytte, Amirsalar Samkani, Arne Astrup, Mogens Fenger, Jan Frystyk, Bolette Hartmann, Jens J. Holst, Thomas M. Larsen, Sten Madsbad, Faidon Magkos, Jens F. Rehfeld, Steen B. Haugaard, Thure Krarup
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
BackgroundCarbohydrate restriction may benefit β-cell function and glucose metabolism in type 2 diabetes (T2D) but also leads to weight loss which in itself is beneficial.MethodsIn order to determine the additional effect of carbohydrate restriction
Externí odkaz:
https://doaj.org/article/8135e6a309234cc6a8411eafd7c863f4
Autor:
Ulrik Ø Andersen, Dijana Terzic, Nicolai Jacob Wewer Albrechtsen, Peter Dall Mark, Peter Plomgaard, Jens F Rehfeld, Finn Gustafsson, Jens P Goetze
Publikováno v:
Endocrine Connections, Vol 9, Iss 5, Pp 438-444 (2020)
Aims: Neprilysin degrades natriuretic peptides in circulation and is also suggested to degrade the gut hormones gastrin and cholecystokinin. Neprilysin inhibition has become a therapeutic strategy and thus a regimen in need of further testing in term
Externí odkaz:
https://doaj.org/article/e6fa5c4b127a4465b5921d4cb30c2447
Publikováno v:
Biology, Vol 11, Iss 7, p 971 (2022)
Production and release of natriuretic peptides and other vasoactive peptides are tightly regulated in mammalian physiology and involved in cardiovascular homeostasis. As endocrine cells, the cardiac myocytes seem to possess almost all known chemical
Externí odkaz:
https://doaj.org/article/314466281ba2411cbe2505e48bbf0703
Autor:
Henriette H. Nerild, Andreas Brønden, Ida M. Gether, Pernille H. Hellmann, Mille Baekdal, Matthew P. Gillum, Jens S. Svenningsen, Bolette Hartmann, Naveen Rathor, Hanna Angelene Kudiyanur Muniraju, Jens F. Rehfeld, Jens J. Holst, Tina Vilsbøll, David P. Sonne, Filip K. Knop
Publikováno v:
Nerild, H H, Brønden, A, Gether, I M, Hellmann, P H, Baekdal, M, Gillum, M P, Svenningsen, J S, Hartmann, B, Rathor, N, Kudiyanur Muniraju, H A, Rehfeld, J F, Holst, J J, Vilsbøll, T, Sonne, D P & Knop, F K 2023, ' Liraglutide changes postprandial responses of gut hormones involved in the regulation of gallbladder motility ', Diabetes, Obesity and Metabolism, vol. 25, no. 6, pp. 1632-1637 . https://doi.org/10.1111/dom.15017
AIM: Liraglutide treatment is associated with gallbladder-related disorders and has been shown to delay postprandial gallbladder refilling. The gut hormones cholecystokinin (CCK), fibroblast growth factor 19 (FGF19) and glucagon-like peptide 2 (GLP-2
Autor:
Isabella Jonsson, Kirstine N. Bojsen-Møller, Viggo B. Kristiansen, Simon Veedfald, Nicolai J. Wewer Albrechtsen, Trine R. Clausen, Rune E. Kuhre, Jens F. Rehfeld, Jens J. Holst, Sten Madsbad, Maria S. Svane
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundAltered bile acid (BA) turnover has been suggested to be involved in the improved glucose regulation after Roux-en-Y gastric bypass (RYGB), possibly via stimulation of GLP-1 secretion. We investigated the role of exogenous as well as endoge
Externí odkaz:
https://doaj.org/article/9ac6a7d255d242b4a97a2771e4672a91
Autor:
Jens F Rehfeld
Publikováno v:
Endocrine Connections, Vol 10, Iss 3, Pp R139-R150 (2021)
The birth certificate for endocrinology was Bayliss’ and Starlin g’s demonstration in 1902 that regulation of bodily functions is not only neuronal but al so due to blood-borne messengers. Starling named these messengers hormones. Since the n tra
Externí odkaz:
https://doaj.org/article/e7998749cb7b43969f50007bd2429adf
Autor:
Ali Asmar, Per K. Cramon, Meena Asmar, Lene Simonsen, Charlotte M. Sorensen, Sten Madsbad, Cedric Moro, Bolette Hartmann, Jens F. Rehfeld, Jens J. Holst, Peter Hovind, Boye L. Jensen, Jens Bülow
Publikováno v:
Physiological Reports, Vol 8, Iss 15, Pp n/a-n/a (2020)
Abstract Human studies have demonstrated that physiologically relevant changes in circulating glucagon‐like peptide‐1 (GLP‐1) elicit a rapid increase in renal sodium excretion when combined with expansion of the extracellular fluid volume. Othe
Externí odkaz:
https://doaj.org/article/5e968996301d4d0cab0fdb4b084fac65